Molecule intelOpportunity: Lower0

Dorzolamide

41 brands · 29 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
25
Market saturation
76
Price room
83
Regulatory risk
50
41
brands
29
companies
Rs 1,047.5
median price
12
price points
4.33x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 7%

Price room

Across observed sources and strengths
CheapestRs 807.41
MedianRs 1,047.5
Most expensiveRs 3,495
Spread4.33×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 4.33x across 12 trusted points (Rs 807.41-3495.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Dorzolamide — each links to its own medicine page.

Regulatory alerts

Safety exposurelatest 2026-04-14
18. Rapid Alert – Spurious TERBIDERM FORTE TABLET (TERBINAFINE 250 mg) & GLANTRIM OPHTHALM

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(83) + 20% low-competition(24) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

29 canonical companies and 41 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 4.33x across 12 trusted points (Rs 807.41-3495.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-04-14 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.